REDWOOD CITY, Calif.— Ascend Clinical, the nation’s leading provider of end-stage renal disease (ESRD) laboratory testing and information delivery services for independent dialysis providers, announced today the appointment of Russell L. Kerschmann, MD as laboratory director.
Kerschmann replaces Dr. Matthew Sakata, who has served as a laboratory director since 1999.
Responsible for overseeing Ascend Clinical’s ESRD-specific laboratory in Redwood City, Kerschmann brings extensive experience in laboratory oversight, including esoteric tests.
Kerschmann received his medical degree from the University of Massachusetts and completed his anatomic and clinical pathology residency at Massachusetts General Hospital. He has held faculty positions at Harvard Medical School, the University of Massachusetts Medical Center and the University of California, San Francisco. He is board certified in anatomic and clinical pathology, and dermatology.
About Ascend Clinical
Ascend Clinical is the ESRD laboratory testing leader for independent dialysis clinics in the United States. LabCheck, LabCheck GO mobile and Ascend Chart deliver the most complete suite of clinical services built for independent dialysis clinics. For more information please visit www.ascendclinical.com.